:

What are the barriers to deprescribing benzodiazepines in older adults in a survey of European physicians?

According to a 2025 survey involving physicians from six European countries, major barriers to deprescribing benzodiazepines (BZRA) include insufficient staff and time, coupled with patient reluctance. The survey was designed to answer the question, "What are the barriers to deprescribing benzodiazepines in older adults in a survey of European physicians?", revealing complex challenges within the healthcare system that hinder effective geriatric care.